Kala Pharmaceuticals (KALA) Misses Q3 EPS by 6c, Revenues Beat
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/8/2026
- Wall St futures decline as oil surge, high yields stoke inflation worries
- Oil jumps as Middle East supply concerns persist amid shipping attacks
- Goldman Sachs sees 18% upside for Palantir on sovereign AI growth
- Citi names 5 top chip picks ahead of Q3 earnings
- PepsiCo shares climb after Q3 beat, though company trims profit forecast
| (NASDAQ: KALA) | Delayed: 0.36 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.36 | 52 Week High | $ | |||
| Open | $0.36 | 52 Week Low | $ | |||
| Day High | $0.36 | P/E | N/A | |||
| Day Low | $0.36 | EPS | $ | |||
| Volume | 36,898 | |||||
